Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study). (2023). SKIN The Journal of Cutaneous Medicine, 7(3), 771-787. https://doi.org/10.25251/skin.7.3.3